Literature DB >> 8024616

Familial spondyloepiphyseal dysplasia tarda, brachydactyly, and precocious osteoarthritis associated with an arginine 75-->cysteine mutation in the procollagen type II gene in a kindred of Chiloe Islanders. I. Clinical, radiographic, and pathologic findings.

A J Reginato1, G M Passano, G Neumann, G F Falasca, M Diaz-Valdez, S A Jimenez, C J Williams.   

Abstract

OBJECTIVE: To characterize a kindred of Chiloe Islanders with spondyloepiphyseal dysplasia tarda (SEDT), brachydactyly, precocious osteoarthritis (OA), and intraarticular calcification.
METHODS: Sixteen family members underwent a complete physical examination, anthropometric measurements, radiographic studies of the spine and peripheral joints, and analysis of the type II procollagen gene (COL2A1).
RESULTS: Seven family members presented with SEDT, brachydactyly, precocious OA, and periarticular calcification while 2 others had the same syndrome but without brachydactyly. The inheritance was autosomal dominant, and the disease cosegregated with a base substitution in the COL2A1 gene.
CONCLUSION: The syndrome o SEDT, precocious OA, and brachydactyly in a kindred of Chiloe Islanders is associated with a point mutation in 1 allele of the COL2A1 gene. The relationship of this type of SEDT to familial calcium pyrophosphate dihydrate deposition disease and idiopathic hip dysplasia, both endemic in Chiloe Islanders, needs to be further investigated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024616     DOI: 10.1002/art.1780370714

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

Review 1.  Familial and clinical aspects of calcium pyrophosphate deposition disease.

Authors:  A J Reginato; E Tamesis; P Netter
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

2.  The phenotypic spectrum in patients with arginine to cysteine mutations in the COL2A1 gene.

Authors:  K P Hoornaert; C Dewinter; I Vereecke; F A Beemer; W Courtens; A Fryer; H Fryssira; M Lees; A Müllner-Eidenböck; D L Rimoin; L Siderius; A Superti-Furga; K Temple; P J Willems; A Zankl; C Zweier; A De Paepe; P Coucke; G R Mortier
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

3.  Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.

Authors:  L J Andrew; V Brancolini; L S de la Pena; M Devoto; F Caeiro; R Marchegiani; A Reginato; A Gaucher; P Netter; P Gillet; D Loeuille; D J Prockop; A Carr; B F Wordsworth; M Lathrop; S Butcher; E Considine; K Everts; A Nicod; S Walsh; C J Williams
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

4.  Variation in the vitreous phenotype of Stickler syndrome can be caused by different amino acid substitutions in the X position of the type II collagen Gly-X-Y triple helix.

Authors:  A J Richards; D M Baguley; J R Yates; C Lane; M Nicol; P S Harper; J D Scott; M P Snead
Journal:  Am J Hum Genet       Date:  2000-09-25       Impact factor: 11.025

Review 5.  Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition.

Authors:  Abhishek Abhishek; Tuhina Neogi; Hyon Choi; Michael Doherty; Ann K Rosenthal; Robert Terkeltaub
Journal:  Arthritis Rheumatol       Date:  2018-06-14       Impact factor: 10.995

Review 6.  The role of structural genes in the pathogenesis of osteoarthritic disorders.

Authors:  Anthony M Reginato; Bjorn R Olsen
Journal:  Arthritis Res       Date:  2002-08-30

7.  Expanding the clinical spectrum of COL2A1 related disorders by a mass like phenotype.

Authors:  Till Joscha Demal; Tasja Scholz; Maja Hempel; Georg Rosenberger; Helke Schüler; Jakob Olfe; Anja Fröhlich; Fabian Speth; Yskert von Kodolitsch; Thomas S Mir; Hermann Reichenspurner; Christian Kubisch
Journal:  Sci Rep       Date:  2022-03-16       Impact factor: 4.379

8.  Early childhood presentation of Czech dysplasia.

Authors:  Lindsay C Burrage; James T Lu; David S Liu; Timothy J Moss; Richard Gibbs; Alan E Schlesinger; Carlos A Bacino; Philippe M Campeau; Brendan H Lee
Journal:  Clin Dysmorphol       Date:  2013-04       Impact factor: 0.816

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.